CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 88 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,009,000 | +0.1% | 83,607 | +4.1% | 0.40% | -15.2% |
| Q4 2018 | $1,008,000 | +3.0% | 80,300 | +21.7% | 0.47% | +49.1% |
| Q3 2018 | $979,000 | +12.8% | 66,000 | +28.0% | 0.32% | -2.2% |
| Q2 2018 | $868,000 | -23.5% | 51,557 | +4.0% | 0.32% | -30.6% |
| Q1 2018 | $1,135,000 | -11.5% | 49,557 | 0.0% | 0.47% | -8.2% |
| Q4 2017 | $1,282,000 | +93.1% | 49,557 | +10.1% | 0.51% | +79.6% |
| Q3 2017 | $664,000 | – | 45,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |